As reported in Table 1, tumor-associated mutations may occur in the whole Shp1 sequence with most mutations (42.27%) in the phosphatase domain; this implies that each specific protein region may be pathologically relevant to cancer development. This evidence concerns the gene PTPN6 and cancer.